These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 7700031

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Dynamics of PTH secretion in hemodialysis patients as determined by the intact and whole PTH assays.
    Santamaria R, Almaden Y, Felsenfeld A, Martin-Malo A, Gao P, Cantor T, Aljama P, Rodriguez M.
    Kidney Int; 2003 Nov; 64(5):1867-73. PubMed ID: 14531822
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure. Rapid communication.
    Antonsen JE, Sherrard DJ, Andress DL.
    Kidney Int; 1998 Jan; 53(1):223-7. PubMed ID: 9453023
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Relation between parathormone and 1,25-dihydroxyvitamin D3 in chronic kidney failure].
    Sotorník I.
    Vnitr Lek; 1997 Sep; 43(9):615-9. PubMed ID: 9750473
    [Abstract] [Full Text] [Related]

  • 52. Effect of intravenous 1-alpha-hydroxyvitamin D3 on secondary hyperparathyroidism in chronic uremic patients on maintenance hemodialysis.
    Brandi L, Daugaard H, Tvedegaard E, Storm T, Olgaard K.
    Nephron; 1989 Sep; 53(3):194-200. PubMed ID: 2797340
    [Abstract] [Full Text] [Related]

  • 53. Impact of the method of calculation on assessment of the PTH-calcium set point.
    Messa P, Turrin D, Mioni G, Cruciatti A.
    Nephrol Dial Transplant; 1997 Jan; 12(1):101-5. PubMed ID: 9027782
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Rate dependence of acute PTH release and association between basal plasma calcium and set point of calcium-PTH curve in dialysis patients.
    De Cristofaro V, Colturi C, Masa A, Comelli M, Pedrini LA.
    Nephrol Dial Transplant; 2001 Jun; 16(6):1214-21. PubMed ID: 11390723
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Calcitonin, an important factor in the calcemic response to parathyroid hormone in the rat.
    Rodriguez M, Felsenfeld AJ, Torres A, Pederson L, Llach F.
    Kidney Int; 1991 Aug; 40(2):219-25. PubMed ID: 1942770
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Hyperparathyroidism, glucose tolerance and platelet intracellular free calcium in chronic renal failure.
    Lu KC, Shieh SD, Lin SH, Chyr SH, Lin YF, Diang LK, Li BL, Sheu WH, Ding YA.
    Q J Med; 1994 Jun; 87(6):359-65. PubMed ID: 8041868
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.